Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Ordinary Shares, $0.01 par value per share
-
Shares outstanding
-
28,961,082
-
Total 13F shares
-
226,747
-
Share change
-
-140,636
-
Total reported value
-
$183,892
-
Price per share
-
$0.80
-
Number of holders
-
13
-
Value change
-
-$164,857
-
Number of buys
-
5
-
Number of sells
-
3
Institutional Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q3 2023
As of 30 Sep 2023,
Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
226,747 shares.
The largest 10 holders included
New Leaf Venture Partners, L.L.C., SUSQUEHANNA INTERNATIONAL GROUP, LLP, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, Kelly Financial Services LLC, NewEdge Advisors, LLC, OSAIC HOLDINGS, INC., and Tower Research Capital LLC (TRC).
This page lists
13
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.